Verified Nov 2026
Other
·
Rueil-Malmaison, Ile-de-France
·
Since 1935
UPSA is a French pharmaceutical company headquartered in Rueil-Malmaison, Ile-de-France, founded in 1935. It is a subsidiary of Taisho Pharmaceutical Holdings Co., Ltd., employs an estimated 1,000 to 5,000 people, and has an estimated revenue band of $500 million to $1 billion. It makes over-the-counter medicines, medical devices and dietary supplements for self-medication, serving the pharmaceutical and medical sectors. In 2025 it announced a collaboration with e-Nable on 3D-printing technology for solidarity projects.
Upsa at a glance
Revenue
$500M-1B
Est. band
Employees
1,000-5,000
Founded
1935
Headquarters
Rueil-Malmaison, Ile-de-France
Industries
Automotive
Electric Vehicles
Medical
Overview
UPSA is a French pharmaceutical company headquartered in Rueil-Malmaison, Ile-de-France, founded in 1935. It is a subsidiary of Taisho Pharmaceutical Holdings Co., Ltd., employs an estimated 1,000 to 5,000 people, and has an estimated revenue band of $500 million to $1 billion. It makes over-the-counter medicines, medical devices and dietary supplements for self-medication, serving the pharmaceutical and medical sectors. In 2025 it announced a collaboration with e-Nable on 3D-printing technology for solidarity projects.
At a glance
Attribute | Detail |
|---|---|
Founded | 1935 |
Headquarters | Rueil-Malmaison, Ile-de-France |
Employees | 1,000-5,000 |
Revenue | $500M-1B (estimated) |
What Upsa makes
The company offers over-the-counter medicines, medical devices and dietary supplements, and holds Origine France Garantie certification for its medicines.
Products and capabilities described on the company's own site include Machining (source: upsa.com).
Latest developments
2026-11-05 — Termination of Proposed Acquisition of UPSA | Company Announcement | Investegate (investegate.co.uk)
2025-11-20 — UPSA certified Origine France Garantie for its medicines (upsa.com)
2025-10-27 — Upsa fait appel à Altmann+Partners - CB News (cbnews.fr)
2025-07-22 — Our press releases - UPSA.com (upsa.com)
2025-07-02 — UPSA & e-Nable: 3D technology serving solidarity (upsa.com)
2025-06-17 — Nos communiqués de presse - UPSA.com (upsa.com)
Company details
UPSA is a subsidiary of Taisho Pharmaceutical Holdings and is privately held, with an estimated revenue band of $500 million to $1 billion. Upsa was founded in 1935, has an estimated 1,000-5,000 employees, and is headquartered in Rueil-Malmaison, Ile-de-France.
Frequently asked questions
What does Upsa do?
UPSA is a French pharmaceutical company headquartered in Rueil-Malmaison, Ile-de-France, founded in 1935. It is a subsidiary of Taisho Pharmaceutical Holdings Co., Ltd., employs an estimated 1,000 to 5,000 people, and has an estimated revenue band of $500 million to $1 billion. It makes over-the-counter medicines, medical devices and dietary supplements for self-medication, serving the pharmaceutical and medical sectors. In 2025 it announced a collaboration with e-Nable on 3D-printing technology for solidarity projects.
Where is Upsa headquartered?
Upsa is headquartered in Rueil-Malmaison, Ile-de-France (3 Rue Joseph Monier, Rueil-Malmaison, Ile-de-France, 92500).
When was Upsa founded?
Upsa was founded in 1935.
How big is Upsa?
Upsa has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.